MacroGenics
The Executive Director, Program and Portfolio Management at MacroGenics is a senior leader responsible for strategic planning, execution, and governance of the company's development portfolio. This role oversees cross‑functional program teams, aligns development plans with corporate priorities, and drives high‑quality decision‑making throughout the product lifecycle.
MacroGenics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies to improve the lives of cancer patients. The company is advancing a broad pipeline of novel product candidates spanning oncology, hematology, and autoimmune applications, including antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and T-cell engagers. MacroGenics has a proven track record of developing FDA-approved therapies in collaboration with global biopharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MacroGenics.
60% above the average for this role
Senior Director of Program Management
Summit Therapeutics,
Director of Program Management
Summit Therapeutics,
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
Director, Oncology R&D Strategy and Portfolio Management
BioLife Plasma Services
IMID Derma Area Executive Director and IMID Therapeutic Area Group (TAG) Support Role
Almirall
Executive Director, Global Program Manager
Kardigan